Laboratory studies demonstrate that combinations of improved senolytic peptides (such as ES2, which shows 3-7 times greater efficacy than FOXO4-DRI) with chemotherapeutic agents like Dabrafenib result in greater elimination of both cancer and senescent cells
It encourages the scar tissue to break down and can: Most people need to use the traction therapy device for several months to see improvement
Similarly, tendon attachments at the spine may develop tendinopathy
Regular use of copper peptides delivers visible improvements such as: Smoother texture and fewer fine lines Improved firmness and elasticity Reduced redness and more balanced tone Enhanced hydration and resilient barrier Most users notice a soft glow within 48 weeks, with deeper collagen and elastin improvements by 12 weeks
Say 2.5mg per injection
We asked Stuart Phillips, professor in the Department of Kinesiology, about the rise of unapproved peptides: the risks, evidence, challenges, and proven alternatives